Subtitle
A physicochemical model of reaction kinetics supports peroxyl radicalrecombination as the main determinant of the FLASH effect.
Subtitle
A physicochemical model of reaction kinetics supports peroxyl radicalrecombination as the main determinant of the FLASH effect.
Proto therapy Time
June 2020
Check full study
Please connect to access this resource and get a more personalized Campus experience
No account yet? Request access
Executive summary
A theoretical model that was developed collaboratively between Pr. Favaudon (Curie) and IBA in an attempt to explain the origin of the FLASH effect. This model predicts that contrary to common belief, the oxygen depletion might not necessarily be the underlying cause of the FLASH effect. Interestingly, this model also predicts that the FLASH effect may occur under normoxic conditions without a substantial depletion of the free O2 in the tissue.
Key content topics
Other popular content
Proton Therapy Publication
December 2021
Technical insights on the treatment of GI cancers.
Proton Therapy Publication
October 2021
Impact of lymphopenia on the clinical outcomes of esophageal cancer patients
Proton Therapy Publication
October 2021
Acute Hematological Outcomes after Proton and Photon Beam Craniospinal Irradiation in Pediatric Brain Tumors
Proton Therapy Publication
October 2021
Acute Hematological Outcomes in Pediatric Brain Tumors
Proton Therapy Publication
October 2021
Comparison of hypothyroidism and adrenal insufficiency in children with medulloblastoma
Proton Therapy Publication
September 2021
Scoping review of patient selection methods for proton therapy
Proton Therapy Publication
September 2021
Dosimetry, efficacy, safety, and cost-effectiveness of PT for NSCLC
Proton Therapy Publication
September 2021
Reduced diffusion in white matter after radiotherapy with photons and protons
Proton Therapy Publication
September 2021
Particle Radiotherapy for Skull Base Chondrosarcoma
Proton Therapy Publication
September 2021
Assessing concordance between patient-reported and investigator-reported CTCAE after PBT for prostate cancer.
Proton Therapy Publication
September 2021
Current status and application of proton therapy for esophageal cancer
Proton Therapy Publication
September 2021
Bicentric Treatment Outcomes following PT for Non-Myxopapillary High-Grade Spinal Cord Ependymoma in Children
Proton Therapy Publication
September 2021
Identifying individualized risk profiles for radiotherapy-induced lymphopenia
Proton Therapy Publication
September 2021
FLASH proton radiotherapy spares normal epithelial and mesenchymal tissues while preserving sarcoma response
Proton Therapy Publication
August 2021
Establishing cost-effective allocation of proton therapy for patients with mediastinal Hodgkin lymphoma